Problem: Just testing things out

Problems

4

Invalid date

Hypotheses

5

Invalid date

Looking at prevalence of co-morbidities in COVID-19 cases allows assessment of risk factors

Alexandra Freeman

18th April 2020, 10:37:43

Creating public and open repositories for COVID data

Alexandra Freeman

18th April 2020, 10:39:19

Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

Alexandra Freeman

13th April 2020, 18:33:15

Studying the clinical course and pathology of severe and mild COVID cases could help

Alexandra Freeman

13th April 2020, 18:46:03

Conducting a meta-analysis of studies of the R0 will help improve estimates

Alexandra Freeman

13th April 2020, 19:06:55

Methods/Protocols

6

Invalid date

Analysis of 45,000 COVID-19 cases

1

Alexandra Freeman

5th April 2020, 11:57:37

A systematic review of COVID-19 cases

Alexandra Freeman

5th April 2020, 19:49:01

A retrospective, multicentre cohort study for adult inpatients in Wuhan, China

Alexandra Freeman

13th April 2020, 16:45:52

Collating public data on COVID, made Open and accessible

Alexandra Freeman

13th April 2020, 17:27:08

Case study of a patient who died of COVID-19 in Wuhan

Alexandra Freeman

13th April 2020, 18:51:59

Method for meta-analysis of studies of R0 for COVID-19

1

Alexandra Freeman

13th April 2020, 19:08:22

Data/Results

6

Invalid date

Data on respiratory co-morbidities in COVID-19, SARS and the general population

Alexandra Freeman

5th April 2020, 12:03:24

Results of systematic review of COVID-19 cases

Alexandra Freeman

5th April 2020, 19:59:28

Results of a retrospective cohort study of 191 inpatients in Wuhan with COVID-19

Alexandra Freeman

13th April 2020, 16:50:11

Data repository of public and Open data on COVID

Alexandra Freeman

13th April 2020, 17:31:19

Results of investigations from a case study of a patient who died of COVID-19 in Wuhan

Alexandra Freeman

13th April 2020, 18:53:34

Results of a meta-analysis of R0 for COVID-19

Alexandra Freeman

13th April 2020, 19:10:12

Analyses

4

Invalid date

Those with chronic respiratory conditions under-represented in COVID-19 cases

Alexandra Freeman

5th April 2020, 12:13:34

Meta-analysis of COVID-19 cases

Alexandra Freeman

5th April 2020, 20:02:13

Analysis of the data from a retrospective cohort study of 191 inpatients in Wuhan with COVID-19

Alexandra Freeman

13th April 2020, 16:52:26

Analysis of the findings from a case study of a patient who died of COVID-19 in Wuhan

Alexandra Freeman

13th April 2020, 18:55:49

Interpretations

4

Invalid date

Could treatment for COPD be protective against COVID-19 symptoms?

Alexandra Freeman

5th April 2020, 12:16:15

Hypertension is the main risk factor, other than age, for COVID-19

Alexandra Freeman

5th April 2020, 20:11:42

A series of 191 inpatients from Wuhan identifies age and other risk factors for COVID-19 prognosis

Alexandra Freeman

13th April 2020, 16:57:26

Interpretation of the results from pathology of a patient who died of COVID-19 in Wuhan

Alexandra Freeman

13th April 2020, 18:59:49

Applications

2

Invalid date

Conclusions from the data on the use of asthma/COPD treatments in COVID-19

Alexandra Freeman

5th April 2020, 12:18:05

Corticosteroid treatment may help prevent ARDS development in COVID-19 patients

Alexandra Freeman

13th April 2020, 19:00:44

Octopus. Built for scientists.

This page has been printed from https://app.science-octopus.org/publications/view/5fb1795feaba54aa7d46b988

Reducing mortality and spread of COVID-19

What is the R0 of the COVID-19 virus?

How can we model the epidemiology of COVID-19?

Just testing things out

Looking at prevalence of co-morbidities in COVID-19 cases allows assessment of risk factors

Creating public and open repositories for COVID data

Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

Studying the clinical course and pathology of severe and mild COVID cases could help

Conducting a meta-analysis of studies of the R0 will help improve estimates

Analysis of 45,000 COVID-19 cases

A systematic review of COVID-19 cases

A retrospective, multicentre cohort study for adult inpatients in Wuhan, China

Collating public data on COVID, made Open and accessible

Case study of a patient who died of COVID-19 in Wuhan

Method for meta-analysis of studies of R0 for COVID-19

Data on respiratory co-morbidities in COVID-19, SARS and the general population

Results of systematic review of COVID-19 cases

Results of a retrospective cohort study of 191 inpatients in Wuhan with COVID-19

Data repository of public and Open data on COVID

Results of investigations from a case study of a patient who died of COVID-19 in Wuhan

Results of a meta-analysis of R0 for COVID-19

Those with chronic respiratory conditions under-represented in COVID-19 cases

Meta-analysis of COVID-19 cases

Analysis of the data from a retrospective cohort study of 191 inpatients in Wuhan with COVID-19

Analysis of the findings from a case study of a patient who died of COVID-19 in Wuhan

Could treatment for COPD be protective against COVID-19 symptoms?

Hypertension is the main risk factor, other than age, for COVID-19

A series of 191 inpatients from Wuhan identifies age and other risk factors for COVID-19 prognosis

Interpretation of the results from pathology of a patient who died of COVID-19 in Wuhan

Conclusions from the data on the use of asthma/COPD treatments in COVID-19

Corticosteroid treatment may help prevent ARDS development in COVID-19 patients

PROBLEM: Just testing things out

Linked Problems

Reviews

Full text

Related publications

Additional information